Are you Dr. Tall?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
New York, NY 10032Phone+1 212-305-4889
Summary
- Dr. Alan Tall, MD is a board certified internist in New York, New York. He is currently licensed to practice medicine in New York. He is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center and New York-Presbyterian Hospital.
Education & Training
- Boston University Medical CenterResidency, Internal Medicine, 1973 - 1975
- University of Sydney Faculty of MedicineClass of 1970
Certifications & Licensure
- NY State Medical License 1978 - 2025
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1982
Publications & Presentations
PubMed
- 166 citationsPlasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis.Alan R. Tall, S Krumholz, T Olivecrona, Richard J. Deckelbaum
Journal of Lipid Research. 1985-07-01 - 221 citationsApolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiencyXian-Cheng Jiang, Shucun Qin, Chunping Qiao, Koichi Kawano, Min Lin
Nature Medicine. 2001-07-01 - 2767 citationsBiological, clinical and population relevance of 95 loci for blood lipidsTanya M. Teslovich, Kiran Musunuru, Albert V. Smith, Andrew C. Edmondson, Ioannis M. Stylianou
Nature. 2010-08-05
Press Mentions
- Anti-Inflammatory Therapies Have Potential to Prevent Heart Disease in the ElderlyMarch 17th, 2021
- CNIC Coordinates a Project from the Leducq FoundationJuly 4th, 2018
- Jewish Grandma’s DNA Points to New Ways of Treating Heart DiseaseMarch 10th, 2016
Grant Support
- Hyperinsulinemia, Mtor Activity And Plasma LipoproteinsNational Heart, Lung, And Blood Institute2012
- ABCG1 And Endothelial FunctionNational Heart, Lung, And Blood Institute2011–2012
- Abca1/Abcg1 In Myeloid Populations And AtherogenesisNational Heart, Lung, And Blood Institute2011
- Insulin Signaling, Lipoproteins And AtherosclerosisNational Heart, Lung, And Blood Institute2007–2011
- Macrophage Foam Cells, Cathepsins And Cholesterol EffluxNational Heart, Lung, And Blood Institute2007–2010
- Novel Pathways Of Cellular Cholesterol EffluxNational Heart, Lung, And Blood Institute2006–2010
- New Genes And Pathways Involved In AtherosclerosisNational Heart, Lung, And Blood Institute2006–2010
- Abca7: Cellular Functions And Role In AtherosclerosisNational Heart, Lung, And Blood Institute2006–2009
- Kern Aspen Lipid ConferenceNational Heart, Lung, And Blood Institute2007
- Administrative CoreNational Heart, Lung, And Blood Institute2006
- Molecular And Cellular Mechanisms Of Chloesterol EffluxNational Heart, Lung, And Blood Institute2004–2006
- Core C--National Heart, Lung, And Blood Institute2004–2006
- The Arterial Wall And Atherogenesis In Mice And HumansNational Heart, Lung, And Blood Institute2002–2006
- Cholesterol Efflux, Foam Cell Formation And DiabetesNational Heart, Lung, And Blood Institute2002–2006
- Novel Pathways Of Cellular Cholesterol EffluxNational Heart, Lung, And Blood Institute2005
- Scavenger Receptor B1 And HDL MetabolismNational Heart, Lung, And Blood Institute1997–2005
- Core A-- Administrative CoreNational Heart, Lung, And Blood Institute2004
- Molecular And Cellular Mechanisms Of Cholesterol EffluxNational Heart, Lung, And Blood Institute2002
- Core--Gene Expression ProfilingNational Heart, Lung, And Blood Institute2002
- Regulation And Function Of Plasma Lipid Transfer ProteinsNational Heart, Lung, And Blood Institute2000–2002
- Gordon Research Conference On Atherosclerosis-2001-02National Heart, Lung, And Blood Institute2001
- Structure/Function Of High Density LipoproteinsNational Heart, Lung, And Blood Institute1997–2001
- Core--Molecular BiologyNational Heart, Lung, And Blood Institute1997–2001
- CETP, HDL And AtherogenesisNational Heart, Lung, And Blood Institute1997–2001
- Arterial Wall And AtherogenesisNational Heart, Lung, And Blood Institute1997–2001
- 2000 Kern Aspen Lipid ConferenceNational Heart, Lung, And Blood Institute2000
- Plasma Cholesteryl Ester Transfer Protein Gene Regulation And FunctionNational Heart, Lung, And Blood Institute1995–1999
- Structure And Function Of High Density LipoproteinsNational Heart, Lung, And Blood Institute1995–1996
- Lipoproteins Atherogenesis And The Arterial WallNational Heart, Lung, And Blood Institute1995–1996
- Gordon Conference On Lipid MetabolismNational Heart, Lung, And Blood Institute1994
- Structure And Function Of High Density LipoproteinsNational Heart, Lung, And Blood Institute1992–1994
- Lipoproteins Atherogenesis And The Arterial WallNational Heart, Lung, And Blood Institute1992–1994
- Nutritional Effects On Transfer Protein Gene ExpressionNational Heart, Lung, And Blood Institute1989–1994
- Structure And Function Of High Density LipoproteinNational Heart, Lung, And Blood Institute1985–1991
- Structure And Function Of High Density LipoproteinsNational Heart, Lung, And Blood Institute1987